Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference60 articles.
1. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.;Nat Microbiol,2020
2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.;Huang;Lancet,2020
3. A novel coronavirus from patients with pneumonia in China, 2019.;Zhu;N Engl J Med,2020
4. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1.;van Doremalen;N Engl J Med,2020
5. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn.;Dong;JAMA,2020
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antiviral activity and underlying mechanisms of baicalin against porcine reproductive and respiratory syndrome virus in vitro;Microbial Pathogenesis;2024-08
2. Significance of Vitamin Supplementation in Reducing the Severity of COVID-19;Mini-Reviews in Medicinal Chemistry;2024-02
3. Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19;Current Neuropharmacology;2023-10
4. Multiple Sclerosis Patients’ COVID-19 Catching Ratios and Disease Profiles;Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi;2023-01-17
5. Thalidomide for the treatment of COVID-19 pneumonia: A randomized controlled clinical trial;Advanced Biomedical Research;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3